Suppr超能文献

通过对包膜蛋白铰链区和假定受体结合区进行定点诱变来减弱墨累谷脑炎病毒

Attenuation of Murray Valley encephalitis virus by site-directed mutagenesis of the hinge and putative receptor-binding regions of the envelope protein.

作者信息

Hurrelbrink R J, McMinn P C

机构信息

Department of Microbiology, University of Western Australia, Nedlands, Western Australia 6907, Australia.

出版信息

J Virol. 2001 Aug;75(16):7692-702. doi: 10.1128/JVI.75.16.7692-7702.2001.

Abstract

Molecular determinants of virulence in flaviviruses cluster in two regions on the three-dimensional structure of the envelope (E) protein; the base of domain II, believed to serve as a hinge during pH-dependent conformational change in the endosome, and the lateral face of domain III, which contains an integrin-binding motif Arg-Gly-Asp (RGD) in mosquito-borne flaviviruses and is believed to form the receptor-binding site of the protein. In an effort to better understand the nature of attenuation caused by mutations in these two regions, a full-length infectious cDNA clone of Murray Valley encephalitis virus prototype strain 1-51 (MVE-1-51) was employed to produce a panel of site-directed mutants with substitutions at amino acid positions 277 (E-277; hinge region) or 390 (E-390; RGD motif). Viruses with mutations at E-277 (Ser-->Ile, Ser-->Asn, Ser-->Val, and Ser-->Pro) showed various levels of in vitro and in vivo attenuation dependent on the level of hydrophobicity of the substituted amino acid. Altered hemagglutination activity observed for these viruses suggests that mutations in the hinge region may indirectly disrupt the receptor-ligand interaction, possibly by causing premature release of the virion from the endosomal membrane prior to fusion. Similarly, viruses with mutations at E-390 (Asp-->Asn, Asp-->Glu, and Asp-->Tyr) were also attenuated in vitro and in vivo; however, the absorption and penetration rates of these viruses were similar to those of wild-type virus. This, coupled with the fact that E-390 mutant viruses were only moderately inhibited by soluble heparin, suggests that RGD-dependent integrin binding is not essential for entry of MVE and that multiple and/or alternate receptors may be involved in cell entry.

摘要

黄病毒毒力的分子决定因素集中在包膜(E)蛋白三维结构的两个区域;结构域II的基部,被认为在内体中pH依赖的构象变化过程中起铰链作用,以及结构域III的侧面,在蚊媒黄病毒中该区域含有整合素结合基序精氨酸 - 甘氨酸 - 天冬氨酸(RGD),被认为形成该蛋白的受体结合位点。为了更好地理解这两个区域的突变引起的减毒性质,使用墨累谷脑炎病毒原型株1 - 51(MVE - 1 - 51)的全长感染性cDNA克隆来产生一组在氨基酸位置277(E - 277;铰链区)或390(E - 390;RGD基序)处有替换的定点突变体。在E - 277处发生突变(丝氨酸→异亮氨酸、丝氨酸→天冬酰胺、丝氨酸→缬氨酸和丝氨酸→脯氨酸)的病毒在体外和体内表现出不同程度的减毒,这取决于被替换氨基酸的疏水性水平。观察到这些病毒的血凝活性改变,表明铰链区的突变可能间接破坏受体 - 配体相互作用,可能是通过在内体膜融合之前导致病毒粒子过早从内体膜释放。同样,在E - 390处发生突变(天冬氨酸→天冬酰胺、天冬氨酸→谷氨酸和天冬氨酸→酪氨酸)的病毒在体外和体内也被减毒;然而,这些病毒的吸附和穿透率与野生型病毒相似。这一点,再加上E - 390突变病毒仅被可溶性肝素适度抑制这一事实,表明RGD依赖的整合素结合对于MVE进入细胞不是必需的,并且多个和/或替代受体可能参与细胞进入。

相似文献

4
Characterization of infectious Murray Valley encephalitis virus derived from a stably cloned genome-length cDNA.
J Gen Virol. 1999 Dec;80 ( Pt 12):3115-3125. doi: 10.1099/0022-1317-80-12-3115.
5
A mouse-attenuated envelope protein variant of Murray Valley encephalitis virus with altered fusion activity.
J Gen Virol. 1996 Sep;77 ( Pt 9):2085-8. doi: 10.1099/0022-1317-77-9-2085.

引用本文的文献

3
Impact of yellow fever virus envelope protein on wild-type and vaccine epitopes and tissue tropism.
NPJ Vaccines. 2022 Mar 23;7(1):39. doi: 10.1038/s41541-022-00460-6.
4
The key amino acids of E protein involved in early flavivirus infection: viral entry.
Virol J. 2021 Jul 3;18(1):136. doi: 10.1186/s12985-021-01611-2.
5
Spectrum of antiviral activity of 4-aminopyrimidine -oxides against a broad panel of tick-borne encephalitis virus strains.
Antivir Chem Chemother. 2020 Jan-Dec;28:2040206620943462. doi: 10.1177/2040206620943462.
6
Small Molecules Targeting the Flavivirus E Protein with Broad-Spectrum Activity and Antiviral Efficacy in Vivo.
ACS Infect Dis. 2019 Mar 8;5(3):460-472. doi: 10.1021/acsinfecdis.8b00322. Epub 2019 Jan 14.
7
Early Events in Japanese Encephalitis Virus Infection: Viral Entry.
Pathogens. 2018 Aug 13;7(3):68. doi: 10.3390/pathogens7030068.
8
African and Asian Zika Virus Isolates Display Phenotypic Differences Both In Vitro and In Vivo.
Am J Trop Med Hyg. 2018 Feb;98(2):432-444. doi: 10.4269/ajtmh.17-0685. Epub 2017 Dec 21.
9
Plasticity of a critical antigenic determinant in the West Nile virus NY99 envelope protein domain III.
Virology. 2016 Sep;496:97-105. doi: 10.1016/j.virol.2016.05.024. Epub 2016 Jun 7.
10
Recovery of West Nile Virus Envelope Protein Domain III Chimeras with Altered Antigenicity and Mouse Virulence.
J Virol. 2016 Apr 14;90(9):4757-4770. doi: 10.1128/JVI.02861-15. Print 2016 May.

本文引用的文献

1
Hemagglutination with arthropod-borne viruses and its inhibition by certain phospholipids.
Virology. 1960 Aug;11:765-70. doi: 10.1016/0042-6822(60)90119-7.
2
Techniques for hemagglutination and hemagglutination-inhibition with arthropod-borne viruses.
Am J Trop Med Hyg. 1958 Sep;7(5):561-73. doi: 10.4269/ajtmh.1958.7.561.
4
Heparan sulfate proteoglycans initiate dengue virus infection of hepatocytes.
Hepatology. 2000 Nov;32(5):1069-77. doi: 10.1053/jhep.2000.18713.
5
Glycosaminoglycan sulfation requirements for respiratory syncytial virus infection.
J Virol. 2000 Nov;74(22):10508-13. doi: 10.1128/jvi.74.22.10508-10513.2000.
8
Recombinant chimeric yellow fever-dengue type 2 virus is immunogenic and protective in nonhuman primates.
J Virol. 2000 Jun;74(12):5477-85. doi: 10.1128/jvi.74.12.5477-5485.2000.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验